Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation
about
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationThrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumoursA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationAlternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationDifferent doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationPathogen-reduced platelets for the prevention of bleedingAlternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.Application of theory to enhance audit and feedback interventions to increase the uptake of evidence-based transfusion practice: an intervention development protocol.Does bleeding affect patient-reported outcome measures in patients with myelodysplasia or hematologic malignancies: a systematic review.Intracranial haemorrhage in thrombocytopenic haematology patients--a nested case-control study: the InCiTe study protocolImpact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation.Platelet transfusion in hematology, oncology and surgery.Platelet transfusions in cancer patients with hypoproliferative thrombocytopenia in the intensive care unitA whole blood model of thrombocytopenia that controls platelet count and hematocrit.Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot studyThe association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantationFlow cytometry and thromboelastography to assess platelet counts and coagulation in patients with haematological malignancies.How to further develop the evidence base for transfusion medicine.A multidimensional approach to assessing intervention fidelity in a process evaluation of audit and feedback interventions to reduce unnecessary blood transfusions: a study protocol.The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions.An epidemiologic cohort study reviewing the practice of blood product transfusions among a population of pediatric oncology patients.Platelet transfusion: a systematic review of the clinical evidence.Pathogen-reduced platelets for the prevention of bleeding.Changing trends in blood transfusion: an analysis of 244,013 hospitalizations.Bleeding complications after central line insertions: relevance of pre-procedure coagulation tests and institutional transfusion policy.Platelet Transfusion Thresholds Among Children Admitted to a Pediatric Intensive Care Unit.Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours.Ultraviolet-Based Pathogen Inactivation Systems: Untangling the Molecular Targets Activated in Platelets.Impaired mitochondrial activity explains platelet dysfunction in thrombocytopenic cancer patients undergoing chemotherapy
P2860
Q24186359-F6DCCA9B-7CE3-4303-AD08-0B3DB26E918DQ24186714-DDF3E988-2352-4AAA-85CB-CD9360497C51Q24186913-0EF296DE-30AA-461A-B7A9-37580142ECE2Q24187751-27CA4638-4BAC-4502-93B0-FBDBDDBBDBA0Q24198288-C3244E28-A522-4E90-9DFF-3A497E870606Q24198774-7F6F89DB-9201-4ACF-B501-3843173CD4F9Q24198795-A960C35F-005E-4A76-813C-589CCD986D1BQ24198832-9DD245B6-CE7B-4196-8B51-CC63DB3196C4Q24199041-F121AA0F-15BB-4DBD-87FC-FCADDCDC42D3Q30248355-A8539B99-081D-4551-9B5E-E45103EA665EQ30601890-E34BCD86-5435-4BE0-BE95-1054E65F3134Q33410860-2B16067C-4FA2-4B58-844E-56D579F283BBQ33413225-39C22B93-427F-487F-8950-9062E96A11C5Q33417080-3EC28D42-0A1D-4E7D-ACA8-36A7747894EEQ33419351-F7FAB637-80B6-43F4-9F03-5CE51F267E69Q33427993-6AA77E05-9434-43EC-8D84-2AE092A63911Q33434527-C4FFFDCF-BF5F-4021-8380-EDC2094A1903Q33436425-1B705B76-B904-42F8-B9A0-865CB6D86F57Q33760834-06A9A91C-D74E-44BF-9595-BD90357F3378Q34416315-54DD6B2E-E6EA-4E1E-8F7F-1992EB2B930BQ36393468-CEC72F14-F2D0-4B2C-82F2-7EEAA89110BDQ37498017-B4BF225F-D674-48D0-8D69-03B4FB10D260Q38073018-254C3A9E-B4A0-4D44-8CEF-EE7307F48E9AQ38207717-A970F863-A789-4761-8514-B8E4BFE9C04AQ38267183-654D06E9-017A-4E31-BE59-25C21D5BC050Q38653240-01BEDA17-CBD3-426A-A89A-4FAD60868EE0Q44337668-2F436C34-A049-4403-A32C-2F8A958AE612Q46261656-DE99DD23-AE9E-4335-A206-2848EDFE9969Q47241256-B15FF2F4-F0A3-4E85-A5A5-446633977B42Q47409875-9D99BF29-B66A-491C-A8B4-9788D12DE174Q54977038-56B683FD-477E-44A8-8FD1-620F91AC2809Q58776882-DD7BDA1B-6AB2-4C69-A174-FEA227EB0F38
P2860
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Prophylactic platelet transfus ...... and stem cell transplantation
@ast
Prophylactic platelet transfus ...... and stem cell transplantation
@en
Prophylactic platelet transfus ...... and stem cell transplantation
@nl
type
label
Prophylactic platelet transfus ...... and stem cell transplantation
@ast
Prophylactic platelet transfus ...... and stem cell transplantation
@en
Prophylactic platelet transfus ...... and stem cell transplantation
@nl
prefLabel
Prophylactic platelet transfus ...... and stem cell transplantation
@ast
Prophylactic platelet transfus ...... and stem cell transplantation
@en
Prophylactic platelet transfus ...... and stem cell transplantation
@nl
P2093
P2860
P50
P1476
Prophylactic platelet transfus ...... and stem cell transplantation
@en
P2093
Alan Tinmouth
Michael F Murphy
Nancy Heddle
P2860
P356
10.1002/14651858.CD004269.PUB3
P577
2012-05-16T00:00:00Z